Susu M. Zughaier

Tawsifur Rahman, Muhammad E. H. Chowdhury, Amith Khandakar et al.

Fast and accurate detection of the disease can significantly help in reducing the strain on the healthcare facility of any country to reduce the mortality during any pandemic. The goal of this work is to create a multimodal system using a novel machine learning framework that uses both Chest X-ray (CXR) images and clinical data to predict severity in COVID-19 patients. In addition, the study presents a nomogram-based scoring technique for predicting the likelihood of death in high-risk patients. This study uses 25 biomarkers and CXR images in predicting the risk in 930 COVID-19 patients admitted during the first wave of COVID-19 (March-June 2020) in Italy. The proposed multimodal stacking technique produced the precision, sensitivity, and F1-score, of 89.03%, 90.44%, and 89.03%, respectively to identify low or high-risk patients. This multimodal approach improved the accuracy by 6% in comparison to the CXR image or clinical data alone. Finally, nomogram scoring system using multivariate logistic regression -- was used to stratify the mortality risk among the high-risk patients identified in the first stage. Lactate Dehydrogenase (LDH), O2 percentage, White Blood Cells (WBC) Count, Age, and C-reactive protein (CRP) were identified as useful predictor using random forest feature selection model. Five predictors parameters and a CXR image based nomogram score was developed for quantifying the probability of death and categorizing them into two risk groups: survived (<50%), and death (>=50%), respectively. The multi-modal technique was able to predict the death probability of high-risk patients with an F1 score of 92.88 %. The area under the curves for the development and validation cohorts are 0.981 and 0.939, respectively.

Nabil Ibtehaz, Muhammad E. H. Chowdhury, Amith Khandakar et al.

Raman spectroscopy provides a vibrational profile of the molecules and thus can be used to uniquely identify different kind of materials. This sort of fingerprinting molecules has thus led to widespread application of Raman spectrum in various fields like medical dignostics, forensics, mineralogy, bacteriology and virology etc. Despite the recent rise in Raman spectra data volume, there has not been any significant effort in developing generalized machine learning methods for Raman spectra analysis. We examine, experiment and evaluate existing methods and conjecture that neither current sequential models nor traditional machine learning models are satisfactorily sufficient to analyze Raman spectra. Both has their perks and pitfalls, therefore we attempt to mix the best of both worlds and propose a novel network architecture RamanNet. RamanNet is immune to invariance property in CNN and at the same time better than traditional machine learning models for the inclusion of sparse connectivity. Our experiments on 4 public datasets demonstrate superior performance over the much complex state-of-the-art methods and thus RamanNet has the potential to become the defacto standard in Raman spectra data analysis

Muhammad E. H. Chowdhury, Nabil Ibtehaz, Tawsifur Rahman et al.

In the break of COVID-19 pandemic, mass testing has become essential to reduce the spread of the virus. Several recent studies suggest that a significant number of COVID-19 patients display no physical symptoms whatsoever. Therefore, it is unlikely that these patients will undergo COVID-19 test, which increases their chances of unintentionally spreading the virus. Currently, the primary diagnostic tool to detect COVID-19 is RT-PCR test on collected respiratory specimens from the suspected case. This requires patients to travel to a laboratory facility to be tested, thereby potentially infecting others along the way.It is evident from recent researches that asymptomatic COVID-19 patients cough and breath in a different way than the healthy people. Several research groups have created mobile and web-platform for crowdsourcing the symptoms, cough and breathing sounds from healthy, COVID-19 and Non-COVID patients. Some of these data repositories were made public. We have received such a repository from Cambridge University team under data-sharing agreement, where we have cough and breathing sound samples for 582 and 141 healthy and COVID-19 patients, respectively. 87 COVID-19 patients were asymptomatic, while rest of them have cough. We have developed an Android application to automatically screen COVID-19 from the comfort of people homes. Test subjects can simply download a mobile application, enter their symptoms, record an audio clip of their cough and breath, and upload the data anonymously to our servers. Our backend server converts the audio clip to spectrogram and then apply our state-of-the-art machine learning model to classify between cough sounds produced by COVID-19 patients, as opposed to healthy subjects or those with other respiratory conditions. The system can detect asymptomatic COVID-19 patients with a sensitivity more than 91%.

Tawsifur Rahman, Amith Khandakar, Yazan Qiblawey et al.

The use of computer-aided diagnosis in the reliable and fast detection of coronavirus disease (COVID-19) has become a necessity to prevent the spread of the virus during the pandemic to ease the burden on the medical infrastructure. Chest X-ray (CXR) imaging has several advantages over other imaging techniques as it is cheap, easily accessible, fast and portable. This paper explores the effect of various popular image enhancement techniques and states the effect of each of them on the detection performance. We have compiled the largest X-ray dataset called COVQU-20, consisting of 18,479 normal, non-COVID lung opacity and COVID-19 CXR images. To the best of our knowledge, this is the largest public COVID positive database. Ground glass opacity is the common symptom reported in COVID-19 pneumonia patients and so a mixture of 3616 COVID-19, 6012 non-COVID lung opacity, and 8851 normal chest X-ray images were used to create this dataset. Five different image enhancement techniques: histogram equalization, contrast limited adaptive histogram equalization, image complement, gamma correction, and Balance Contrast Enhancement Technique were used to improve COVID-19 detection accuracy. Six different Convolutional Neural Networks (CNNs) were investigated in this study. Gamma correction technique outperforms other enhancement techniques in detecting COVID-19 from standard and segmented lung CXR images. The accuracy, precision, sensitivity, f1-score, and specificity in the detection of COVID-19 with gamma correction on CXR images were 96.29%, 96.28%, 96.29%, 96.28% and 96.27% respectively. The accuracy, precision, sensitivity, F1-score, and specificity were 95.11 %, 94.55 %, 94.56 %, 94.53 % and 95.59 % respectively for segmented lung images. The proposed approach with very high and comparable performance will boost the fast and robust COVID-19 detection using chest X-ray images.

Muhammad E. H. Chowdhury, Tawsifur Rahman, Amith Khandakar et al.

COVID-19 pandemic has created an extreme pressure on the global healthcare services. Fast, reliable and early clinical assessment of the severity of the disease can help in allocating and prioritizing resources to reduce mortality. In order to study the important blood biomarkers for predicting disease mortality, a retrospective study was conducted on 375 COVID-19 positive patients admitted to Tongji Hospital (China) from January 10 to February 18, 2020. Demographic and clinical characteristics, and patient outcomes were investigated using machine learning tools to identify key biomarkers to predict the mortality of individual patient. A nomogram was developed for predicting the mortality risk among COVID-19 patients. Lactate dehydrogenase, neutrophils (%), lymphocyte (%), high sensitive C-reactive protein, and age - acquired at hospital admission were identified as key predictors of death by multi-tree XGBoost model. The area under curve (AUC) of the nomogram for the derivation and validation cohort were 0.961 and 0.991, respectively. An integrated score (LNLCA) was calculated with the corresponding death probability. COVID-19 patients were divided into three subgroups: low-, moderate- and high-risk groups using LNLCA cut-off values of 10.4 and 12.65 with the death probability less than 5%, 5% to 50%, and above 50%, respectively. The prognostic model, nomogram and LNLCA score can help in early detection of high mortality risk of COVID-19 patients, which will help doctors to improve the management of patient stratification.